Milestone Scientific (NYSE:MLSS) Stock Price Down 4.9% – Time to Sell?

Milestone Scientific Inc. (NYSE:MLSS) was down 4.9% during mid-day trading on Wednesday . The stock traded as low as $0.2975 and last traded at $0.31. Approximately 432,611 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 1,625,806 shares. The stock had previously closed at $0.3259.

Milestone Scientific Stock Performance

The firm’s 50 day simple moving average is $0.29 and its 200 day simple moving average is $0.32. The firm has a market capitalization of $27.19 million, a price-to-earnings ratio of -4.83 and a beta of 0.85.

Institutional Investors Weigh In On Milestone Scientific

A hedge fund recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. raised its holdings in Milestone Scientific Inc. (NYSE:MLSS) by 416.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 62,000 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Raymond James Financial Inc. owned 0.08% of Milestone Scientific worth $39,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.